DCOY Financials

Income Statement
MetricQ2 2026Q1 2026
Revenue
227.6K
0
Cost of Revenue
0
0
Gross Profit
227.6K
0
Operating Expenses
2.6M
+15.2%
2.3M
R&D
1.3M
+74.0%
749.8K
SG&A
1.3M
-13.5%
1.5M
Operating Income
-2403392
-5.2%
-2283739
EBITDA
-2389760
-4.9%
-2277815
Net Income
-2373800
-6.7%
-2224628
EPS (Basic)
$-4.46
-6.7%
$-4.18
EPS (Diluted)
$-4.46
-6.7%
$-4.18
Shares (Diluted)
532.0K
+0.0%
532.0K
Decoy Therapeutics (DCOY) โ€” Financials